USANA HEALTH SCIENCES, INC. Proceeds from Collection of Notes Receivable
USANA HEALTH SCIENCES, INC. (USNA) reported Proceeds from Collection of Notes Receivable of $0 for the 12-month period ending 2023-12-30, per its 10-K filed 2024-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfNotesReceivable · last filed 2024-02-27
- USANA HEALTH SCIENCES, INC. proceeds from collection of notes receivable for the quarter ending 2022-12-31 was $0.00.
- USANA HEALTH SCIENCES, INC. proceeds from collection of notes receivable for the quarter ending 2022-10-01 was $0.00, a 100.00% decline year-over-year.
- USANA HEALTH SCIENCES, INC. proceeds from collection of notes receivable for the quarter ending 2022-07-02 was $0.00, a 100.00% decline year-over-year.
- USANA HEALTH SCIENCES, INC. proceeds from collection of notes receivable for the quarter ending 2022-04-02 was $0.00, a 100.00% decline year-over-year.
- USANA HEALTH SCIENCES, INC. proceeds from collection of notes receivable for fiscal 2023 was $0.00.
- USANA HEALTH SCIENCES, INC. proceeds from collection of notes receivable for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. proceeds from collection of notes receivable for fiscal 2022 was $116.00K, a 58.72% decline from fiscal 2021.
- USANA HEALTH SCIENCES, INC. proceeds from collection of notes receivable for fiscal 2021 was $281.00K, a 21.65% increase from fiscal 2019.
| Period end | Proceeds from Collection of Notes Receivable 3 month | Proceeds from Collection of Notes Receivable 6 month | Proceeds from Collection of Notes Receivable 9 month | Proceeds from Collection of Notes Receivable 12 month |
|---|---|---|---|---|
| 2023-12-30 | $0.00 10-K · filed 2024-02-27 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 |
| 2022-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $12.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $0.00 10-Q · filed 2022-05-11 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $12.00K derived: sum of 3 quarters · filed 2024-02-27 | $65.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-01-01 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $12.00K derived: sum of 2 quarters · filed 2024-02-27 | $65.00K derived: sum of 3 quarters · filed 2024-02-27 | $116.00K 10-K · filed 2024-02-27 |
| 2021-10-02 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $65.00K derived: sum of 2 quarters · filed 2022-11-08 | $116.00K 10-Q · filed 2022-11-08 | $161.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-07-03 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $104.00K 10-Q · filed 2022-08-09 | $149.00K derived: sum of 3 quarters · filed 2023-02-28 | $206.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-04-03 | $51.00K 10-Q · filed 2022-05-11 | $96.00K derived: sum of 2 quarters · filed 2023-02-28 | $153.00K derived: sum of 3 quarters · filed 2023-02-28 | $247.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-01-02 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $102.00K derived: sum of 2 quarters · filed 2023-02-28 | $196.00K derived: sum of 3 quarters · filed 2023-02-28 | $281.00K 10-K · filed 2023-02-28 |
| 2020-09-26 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $151.00K derived: sum of 2 quarters · filed 2021-11-10 | $236.00K 10-Q · filed 2021-11-10 | $322.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-27 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $179.00K 10-Q · filed 2021-08-11 | $265.00K derived: sum of 3 quarters · filed 2022-03-01 | $318.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-28 | $85.00K 10-Q · filed 2021-05-11 | $171.00K derived: sum of 2 quarters · filed 2022-03-01 | $224.00K derived: sum of 3 quarters · filed 2022-03-01 | $261.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-28 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $139.00K derived: sum of 2 quarters · filed 2022-03-01 | $176.00K derived: sum of 3 quarters · filed 2022-03-01 | $231.00K 10-K · filed 2022-03-01 |
| 2019-09-28 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $90.00K derived: sum of 2 quarters · filed 2020-11-03 | $145.00K 10-Q · filed 2020-11-03 | $193.00K derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-29 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $92.00K 10-Q · filed 2020-08-04 | $140.00K derived: sum of 3 quarters · filed 2021-03-02 | $181.00K derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-30 | $55.00K 10-Q · filed 2020-05-05 | $103.00K derived: sum of 2 quarters · filed 2021-03-02 | $144.00K derived: sum of 3 quarters · filed 2021-03-02 | $4.60M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-29 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $89.00K derived: sum of 2 quarters · filed 2021-03-02 | $4.55M derived: sum of 3 quarters · filed 2021-03-02 | $4.85M 10-K · filed 2021-03-02 |
| 2018-09-29 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $4.50M derived: sum of 2 quarters · filed 2019-11-05 | $4.80M 10-Q · filed 2019-11-05 | $4.84M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $4.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $4.76M 10-Q · filed 2019-08-06 | $4.80M derived: sum of 3 quarters · filed 2020-02-25 | $4.80M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $301.00K 10-Q · filed 2019-05-07 | $338.00K derived: sum of 2 quarters · filed 2020-02-25 | $338.00K derived: sum of 3 quarters · filed 2020-02-25 | $490.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-30 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $37.00K derived: sum of 2 quarters · filed 2020-02-25 | $189.00K derived: sum of 3 quarters · filed 2020-02-25 | $296.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $152.00K derived: sum of 2 quarters · filed 2018-11-07 | $259.00K 10-Q · filed 2018-11-07 | $465.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-07-01 | $152.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $259.00K 10-Q · filed 2018-08-08 | $465.00K derived: sum of 3 quarters · filed 2019-02-26 | $627.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-04-01 | $107.00K 10-Q · filed 2018-05-09 | $313.00K derived: sum of 2 quarters · filed 2019-02-26 | $475.00K derived: sum of 3 quarters · filed 2019-02-26 | $869.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $368.00K derived: sum of 2 quarters · filed 2019-02-26 | $762.00K derived: sum of 3 quarters · filed 2019-02-26 | $811.00K 10-K · filed 2019-02-26 |
| 2016-10-01 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $556.00K derived: sum of 2 quarters · filed 2017-11-08 | $605.00K 10-Q · filed 2017-11-08 | |
| 2016-07-02 | $394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $443.00K 10-Q · filed 2017-08-09 | ||
| 2016-04-02 | $49.00K 10-Q · filed 2017-05-10 | |||
| 2010-01-02 | $245.00K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |